Skip to main content

Cafepharma Today

August 26 2025 - Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval

Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Eli Lilly board
Terumo to buy OrganOx for $1.5B to enter transplant field
Terumo board
Trump, Kennedy could ban COVID-19 vaccine ‘within months’: report
Moderna board, Pfizer board
MannKind grabs scPharmaceuticals and its heart failure infuser Furoscix in $360M deal
MannKind board
*please scroll down for all the latest news*

Check open job listings in your area
Click here to the top four headlines in your inbox Mon-Fri (free)

learn about pharmaceutical fraud
learn about the False Claims Act

Current News



Latest CP Wire Articles

Top 15 Pharmaceutical Companies for Salespeople in 2025
Top 20 Medical Device Companies for Salespeople in 2025
AbbVie announces a $195 million investment in US API manufacturing
Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader [release]
Radella Pharmaceuticals’ peptide obesity drug shows improved cardiovascular markers and muscle-sparing weight loss in trial
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling [release]
Kedrion Biopharma Receives Orphan Drug Designation for COAGADEX® for Acquired Factor X Deficiency (aFXD) and Starts Clinical Trial to Evaluate Efficacy and Safety [release]
Creative Biolabs Conducts a Webinar on Tumoroid-on-a-Chip Model for Immunotherapy
Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?

Latest Pharmagather Articles